IP Library Granted Patent US 11,890,480
Granted Patent B2
US 11,890,480 · App. 16/741,214 · Granted Feb 6, 2024

Therapy implemented using different sub-perception neuromodulation types

Inventor: Michael A. Moffitt (Solon, OH)
Assignee: Boston Scientific Neuromodulation Corporation
A61N1/36167A61N1/025A61N1/36062A61N1/36071A61N1/36132
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,890,480
App. No.
16/741,214
Granted
Feb 6, 2024
Kind
B2
Abstract

A neuromodulation system for use with electrodes to modulate a volume of neural tissue may include a waveform generator and a controller. The waveform generator may be configured to be electrically connected to the electrodes and provide an electrical waveform through at least some of the electrodes to provide a neuromodulation therapy. The controller may be configured to use a program to control the waveform generator to deliver a neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation. The fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in transition period more than a second time duration, the second time duration being longer than the first time duration.

Claims (25)

1. A method, comprising:

delivering a spinal cord neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation to a spinal cord of a patient using one or more electrodes implanted adjacent to the spinal cord,

wherein the fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in transition period more than a second time duration, the second time duration being longer than the first time duration.

2. The method of claim 1 , wherein the neuromodulation therapy is to treat chronic pain.

3. The method of claim 1 , wherein the delivering both the fast-acting sub-perception neuromodulation and the slow-acting sub-perception neuromodulation includes delivering the fast-acting sub-perception neuromodulation using a timing channel and delivering the slow-acting sub-perception neuromodulation using the timing channel.

4. The method of claim 1 , wherein the delivering both the fast-acting sub-perception neuromodulation and the slow-acting sub-perception neuromodulation includes delivering the fast-acting sub-perception neuromodulation using a timing channel and delivering the slow-acting sub-perception neuromodulation using a different timing channel.

5. The method of claim 1 , wherein the delivering both the fast-acting sub- perception neuromodulation and the slow-acting sub-perception neuromodulation includes initiating the fast-acting sub-perception neuromodulation and the slow-acting sub-perception neuromodulation together.

6. The method of claim 1 , wherein the delivering both the fast-acting sub-perception neuromodulation and the slow-acting sub-perception neuromodulation includes initiating the fast-acting sub-perception neuromodulation before or after initiating the slow-acting sub-perception neuromodulation.

7. The method of claim 1 , wherein the delivering both the fast-acting sub-perception neuromodulation and the slow-acting sub-perception neuromodulation includes terminating the fast-acting sub-perception neuromodulation before terminating the slow-acting sub-perception.

8. The method of claim 1 , wherein the delivering both the fast-acting sub-perception neuromodulation and the slow-acting sub-perception neuromodulation includes intermittently delivering the fast-acting sub-perception neuromodulation multiple times during the slow-acting sub-perception neuromodulation.

9. The method of claim 1 , wherein a duration of the fast-acting sub-perception neuromodulation is shorter than a duration of the slow-acting sub-perception neuromodulation.

10. The method of claim 1 , further comprising testing two or more neuromodulation programs according to a program schedule, wherein each of the two or more neuromodulation programs includes programmed modulation parameter sets to control delivery of the slow-acting sub-perception neuromodulation and the fast-acting sub-perception neuromodulation.

11. The method of claim 10 , wherein the programmed modulation parameter sets include programmed modulation parameter sets to provide different slow-acting sub-perception neuromodulation areas.

12. The method of claim 10 , wherein the program schedule is configured for use to deliver slow-acting sub-perception neuromodulation to individual ones of the different slow-acting sub-perception neuromodulation areas for a duration longer than 12 hours.

13. The method of claim 10 , wherein the programmed modulation parameter sets include programmed modulation parameter sets to provide different slow-acting sub-perception neuromodulation amplitudes.

14. The method of claim 10 , further comprising intermittently reprogramming the fast-acting sub-perception neuromodulation during the program schedule, wherein the intermittently reprogramming includes determining a supra-perception neuromodulation parameter set that provides effective supra-perception neuromodulation, and responding to a user input by automatically determining a modified fast-acting sub-perception neuromodulation parameter set based on the supra-perception neuromodulation parameter set.

15. The method of claim 1 , further comprising terminating the fast-acting sub-perception neuromodulation in response to a user input.

16. The method of claim 1 , further comprising terminating the slow-acting sub-perception neuromodulation in response to a user input.

17. The method of claim 1 , wherein the delivering the neuromodulation therapy includes responding to a user input by initiating the fast-acting sub-perception neuromodulation or initiating the slow-acting sub-perception neuromodulation.

18. A neuromodulation system for use with electrodes to modulate a volume of neural tissue, comprising:

a waveform generator configured to be electrically connected to the electrodes and provide an electrical waveform through at least some of the electrodes to provide a spinal cord neuromodulation therapy, wherein the electrodes are configured to be implanted adjacent to a spinal cord of a patient; and

a controller configured to use a program to control the waveform generator to deliver the neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation to the spinal cord of the patient, wherein the fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in transition period more than a second time duration, the second time duration being longer than the first time duration.

19. A non-transitory machine-readable medium including instructions, which when executed by a machine, cause the machine to configure a program for a neurostimulator that is capable of providing a spinal cord neurostimulation therapy, the instructions causing the machine to configure the program to cause the neurostimulator to:

deliver the neuromodulation therapy by delivering both a fast-acting sub-perception neuromodulation and a slow-acting sub-perception neuromodulation to a spinal cord of a patient using one or more electrodes implanted adjacent to the spinal cord,

wherein the fast-acting neuromodulation has a wash-in transition period less than a first time duration, and the slow-acting sub-perception neuromodulation has a wash-in period more than a second time duration, the second time duration being longer than the first time duration.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2020
From: MOFFITT, MICHAEL A.
To: BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Reel/Frame 051498/0624 →
Continuity (7)
Continuation In Part 16738786 · Jan 9, 2020
Continuation In Part 16657560 · Oct 18, 2019
Continuation In Part 16100904 · Aug 10, 2018
Continuation In Part 16460655 · Jul 2, 2019
Provisional Application 62802844 · Feb 8, 2019
Provisional Application 62693543 · Jul 3, 2018
Related Publication 20200147391A1 · May 14, 2020